However, programmed cell death-ligand 1 (PD-L1) on the surface of tumor cells binds to the activated CD8+ T cell receptor programmed cell death-1 (PD-1), which significantly inhibits the ability of CD8+ T cells to kill tumor cells. The gene discussed is CD8A; the disease is neoplasm.